COVID-19 Vaccine Information for Providers

All individuals 12 years of age and older who reside in the United States are eligible to be vaccinated. See guidance regarding necessary consent for individuals under 18 years of age.

Guidance for additional mRNA COVID-19 vaccine dose after an initial 2-dose COVID-19 mRNA vaccine series for immunocompromised people. 

The following document provides COVID-19 vaccination prioritization and allocation framework for Emergency Medical Services Personnel, for weeks 1-4 (through January 10, 2021).

On September 24, 2021, under the US Food and Drug Administration (FDA) amended emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, the CDC issued recommendations for a single booster dose for individuals 65 years of age or older, as well as long-term care facility residents; individuals age 50-64 with underlying medical conditions; individuals age 18-49 with underlying medical conditions, based on individual benefit and risk; and individuals age 18-64 who are at an increased risk for COVID-19 exposure or transmission because of occupational or institutional setting. Underlying conditions and occupational settings are enumerated below.

Updated Sept. 24, 2021. This document provides information for Healthcare Professionals about the Screening Checklist for the COVID-19 Vaccine.

Information for Health Care Professionals about the Screening Checklist for the COVID-19 Vaccine

COVID-19 Immunization Screening and Consent Form

Role of Inventory Management and Reporting Doses Administered in review of Vaccine Planning Requests

How to Manually Modify Inventory in NYSIIS

NYSIIS Inventory Not Deducted Cheat Sheet

Aug. 27, 2021 - Important reminder for all health care providers.

Although standards for vaccine administration typically do not include predrawing (also known as “prefilling”) of syringes due to concerns over compromising or wasting vaccine, the Centers for Disease Control and Prevention (CDC) has permitted predrawing for COVID-19 vaccines, subject to certain qualifications.

Recommendations to Resume Use of the Janssen/Johnson & Johnson COVID-19 Vaccine

Guidance for hospitals vaccinating long-term care patients before discharge to a long-term care facility.

Also available in: Español, 한국어 번역, русский язык, 中文翻譯, বাংলা অনুবাদ, and Kreyòl Ayisyen.

Routine transport of vaccine is not recommended. Each transport increases the risk of exposing vaccine to inappropriate storage conditions, which compromises the viability of vaccines. However, in certain situations transporting vaccine may be necessary. Opened vials cannot be transported.

Also available in: Español, 한국어 번역, русский язык, 中文翻譯, বাংলা অনুবাদ, and Kreyòl Ayisyen.

Provides guidance on the EUA issued by the U.S. Food & Drug Administration.

Complete this report to gather information vaccine manufacturers will need to make a stability determination. 

Also available in: Español, 한국어 번역, русский язык, 中文翻譯, বাংলা অনুবাদ, and Kreyòl Ayisyen.

Information for providers about the vaccine distribution process. 

Recipients of the Pfizer-BioNTech vaccine are to receive these two doses 21 days apart, and recipients of the Moderna vaccine are to receive these two doses 28 days apart. 

Information for vaccine providers on how to redistribute the COVID-19 vaccine.

Please review the information in this letter and each of the referenced resource documents (links provided) and complete the enrollment application in the HCS online application tool.

This certification permits licensed physicians and certified nurse practitioners to issue a non-patient specific order to pharmacists for the administration of COVID-19 vaccine.

Updated Sept. 24, 2021. Providers may use this form to obtain and record patient consent to receive the COVID-19 vaccine, prior to administration.

NYSDOH guidance on withdrawing more than five doses from one vial of the Pfizer/BioNTech vaccine.

Guidance for vaccine providers who may be able to withdraw more than 10 doses from a single 10-dose vial.

The following document provides guidance to remind all authorized vaccine administrators concerning requirements reragring the New York State Immunization Information System (NYSIIS) and City Immunization Registry (CIR). 

This letter provides additional detail on the establishment of Regional Vaccination Networks and clarifies the role of health care providers in this effort and emphasizes the expectation that health care providers fully participate in their local Regional Vaccination Network.

This document provides information for Healthcare Professionals about the New York State COVID-19 Vaccine Form.

Overview of the COVID-19 Vaccination Provider Storage and Handling Requirements

Information for vaccine providers on who can administer COVID-19 vaccinations.